CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 1 filers reported holding CARDIOME PHARMA CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $71,000 | +57.8% | 30,800 | +5.1% | 0.00% | – |
Q4 2017 | $45,000 | +150.0% | 29,300 | +602.8% | 0.00% | – |
Q2 2017 | $18,000 | +1700.0% | 4,169 | +733.8% | 0.00% | – |
Q4 2016 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
Q3 2016 | $1,000 | -50.0% | 500 | +25.0% | 0.00% | – |
Q2 2016 | $2,000 | -98.5% | 400 | -97.3% | 0.00% | – |
Q2 2015 | $137,000 | +813.3% | 14,599 | +769.5% | 0.00% | – |
Q1 2015 | $15,000 | +150.0% | 1,679 | +106.0% | 0.00% | – |
Q2 2014 | $6,000 | -45.5% | 815 | -42.6% | 0.00% | – |
Q1 2014 | $11,000 | +450.0% | 1,420 | +255.0% | 0.00% | – |
Q4 2013 | $2,000 | -96.9% | 400 | -97.8% | 0.00% | – |
Q3 2013 | $64,000 | – | 18,299 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alistair Capital Management, L.L.C. | 917,400 | $5,715,000 | 2.56% |
Fortress Investment Group LLC | 2,481,596 | $15,460,000 | 0.24% |
PERKINS CAPITAL MANAGEMENT INC | 14,000 | $87,000 | 0.06% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,332,260 | $8,386,000 | 0.02% |
TFS CAPITAL LLC | 26,116 | $163,000 | 0.01% |
GROUP ONE TRADING, L.P. | 54,815 | $342,000 | 0.01% |
Renaissance Technologies | 218,913 | $1,364,000 | 0.00% |
Alberta Investment Management Corp | 19,140 | $128,000 | 0.00% |
OAK RIDGE INVESTMENTS LLC | 11,055 | $69,000 | 0.00% |
SUMMIT SECURITIES GROUP LLC | 600 | $4,000 | 0.00% |